カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/06 | 1,485 | 1,494 | 1,445 | 1,458 | -29 | -2% | 55,300 |
2018/09/05 | 1,500 | 1,530 | 1,480 | 1,487 | -21 | -1.4% | 69,400 |
2018/09/04 | 1,572 | 1,573 | 1,505 | 1,508 | -63 | -4% | 138,700 |
2018/09/03 | 1,561 | 1,601 | 1,561 | 1,571 | -30 | -1.9% | 85,900 |
2018/08/31 | 1,595 | 1,605 | 1,575 | 1,601 | +5 | +0.3% | 52,900 |
2018/08/30 | 1,603 | 1,609 | 1,571 | 1,596 | -12 | -0.7% | 88,200 |
2018/08/29 | 1,617 | 1,632 | 1,595 | 1,608 | -2 | -0.1% | 69,300 |
2018/08/28 | 1,626 | 1,646 | 1,569 | 1,610 | +14 | +0.9% | 253,700 |
2018/08/27 | 1,532 | 1,600 | 1,532 | 1,596 | +64 | +4.2% | 113,000 |
2018/08/24 | 1,510 | 1,548 | 1,510 | 1,532 | +28 | +1.9% | 181,300 |
2018/08/23 | 1,456 | 1,506 | 1,456 | 1,504 | +49 | +3.4% | 77,100 |
2018/08/22 | 1,421 | 1,470 | 1,421 | 1,455 | +39 | +2.8% | 40,600 |
2018/08/21 | 1,427 | 1,446 | 1,412 | 1,416 | -15 | -1% | 29,400 |
2018/08/20 | 1,424 | 1,459 | 1,408 | 1,431 | +34 | +2.4% | 33,800 |
2018/08/17 | 1,394 | 1,428 | 1,383 | 1,397 | +7 | +0.5% | 38,600 |
2018/08/16 | 1,390 | 1,404 | 1,377 | 1,390 | -13 | -0.9% | 25,300 |
2018/08/15 | 1,457 | 1,460 | 1,390 | 1,403 | -42 | -2.9% | 59,800 |
2018/08/14 | 1,387 | 1,457 | 1,387 | 1,445 | +56 | +4% | 47,700 |
2018/08/13 | 1,472 | 1,473 | 1,389 | 1,389 | -83 | -5.6% | 94,900 |
2018/08/10 | 1,384 | 1,589 | 1,384 | 1,472 | +91 | +6.6% | 345,200 |
2018/08/09 | 1,380 | 1,388 | 1,361 | 1,381 | -3 | -0.2% | 14,700 |
2018/08/08 | 1,351 | 1,390 | 1,350 | 1,384 | +21 | +1.5% | 43,000 |
2018/08/07 | 1,414 | 1,440 | 1,350 | 1,363 | -74 | -5.1% | 88,500 |
2018/08/06 | 1,458 | 1,477 | 1,430 | 1,437 | -24 | -1.6% | 35,500 |
2018/08/03 | 1,467 | 1,494 | 1,460 | 1,461 | -23 | -1.5% | 51,900 |
2018/08/02 | 1,440 | 1,487 | 1,430 | 1,484 | +45 | +3.1% | 60,900 |
2018/08/01 | 1,454 | 1,467 | 1,436 | 1,439 | -24 | -1.6% | 34,100 |
2018/07/31 | 1,400 | 1,468 | 1,383 | 1,463 | +50 | +3.5% | 56,600 |
2018/07/30 | 1,453 | 1,453 | 1,402 | 1,413 | -40 | -2.8% | 53,900 |
2018/07/27 | 1,450 | 1,470 | 1,430 | 1,453 | +10 | +0.7% | 53,200 |
2018/07/26 | 1,430 | 1,447 | 1,414 | 1,443 | +8 | +0.6% | 42,500 |
2018/07/25 | 1,410 | 1,436 | 1,407 | 1,435 | +32 | +2.3% | 49,400 |
2018/07/24 | 1,410 | 1,414 | 1,381 | 1,403 | -7 | -0.5% | 28,000 |
2018/07/23 | 1,393 | 1,418 | 1,384 | 1,410 | +21 | +1.5% | 56,500 |
2018/07/20 | 1,354 | 1,389 | 1,347 | 1,389 | +20 | +1.5% | 45,900 |
2018/07/19 | 1,361 | 1,374 | 1,346 | 1,369 | +17 | +1.3% | 42,900 |
2018/07/18 | 1,290 | 1,369 | 1,290 | 1,352 | +62 | +4.8% | 100,300 |
2018/07/17 | 1,304 | 1,312 | 1,280 | 1,290 | -22 | -1.7% | 42,400 |
2018/07/13 | 1,319 | 1,325 | 1,306 | 1,312 | -9 | -0.7% | 20,400 |
2018/07/12 | 1,319 | 1,346 | 1,315 | 1,321 | +2 | +0.2% | 25,600 |
2018/07/11 | 1,310 | 1,323 | 1,294 | 1,319 | -3 | -0.2% | 19,700 |
2018/07/10 | 1,350 | 1,351 | 1,305 | 1,322 | -3 | -0.2% | 64,800 |
2018/07/09 | 1,269 | 1,327 | 1,260 | 1,325 | +79 | +6.3% | 82,200 |
2018/07/06 | 1,215 | 1,258 | 1,201 | 1,246 | +60 | +5.1% | 75,500 |
2018/07/05 | 1,288 | 1,288 | 1,172 | 1,186 | -87 | -6.8% | 138,900 |
2018/07/04 | 1,296 | 1,309 | 1,260 | 1,273 | -22 | -1.7% | 66,800 |
2018/07/03 | 1,318 | 1,345 | 1,292 | 1,295 | -11 | -0.8% | 74,400 |
2018/07/02 | 1,335 | 1,337 | 1,303 | 1,306 | -13 | -1% | 41,600 |
2018/06/29 | 1,301 | 1,326 | 1,300 | 1,319 | +11 | +0.8% | 41,400 |
2018/06/28 | 1,290 | 1,330 | 1,288 | 1,308 | -30 | -2.2% | 97,500 |
1501~
1550
件表示中 / 3572件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 30,400円 | -43.1% | - | 0.00% | - | 1.81倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
カイオム | 9,900円 | +2.6% | - | 0.00% | - | 5.73倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
VIS | 91,000円 | +87.8% | +265.7% | 0.00% | 54.65倍 | 2.51倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 82,300円 | +14.5% | - | 0.00% | - | 2.43倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
DELTA-P | 65,800円 | - | - | 0.00% | - | 4.40倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム